The pharmacokinetics of orbifloxacin in the horse following oral and intravenous administration

Journal of Veterinary Pharmacology and Therapeutics

Volumn 29, Issue 3, 2006, Pages 191-197

  Davis, J L ^a   Papich, M G ^a   Weingarten, A ^b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTANOL; ORBIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; WATER;

ALKALINITY; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG HALF LIFE; DRUG PROTEIN BINDING; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORSE; LIPOPHILICITY; MALE; NONHUMAN; PARTITION COEFFICIENT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; CIPROFLOXACIN; CROSS-OVER STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HORSES; INFUSIONS, INTRAVENOUS; MALE; PROTEIN BINDING;

ANIMALIA; BACTERIA (MICROORGANISMS); EQUIDAE; EQUUS CABALLUS;

EID: 33646271858     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2006.00737.x     Document Type: Article

References (33)

1. Ambrose P.G. Grasela D.M. 2000 The use of Monte Carlo simulation to examine pharmacodynamic variance of drugs: fluoroquinolone pharmacodynamics against Streptococcus pneumoniae Diagnostic Microbiology and Infectious Disease 38 151 157
2. Amidon G.L. Lennernas H. Shah V.P. Crison J.R. 1995 A theoretical basis for a biopharmaceutic drug classification: the correlation of an in vitro drug product dissolution and in vivo bioavailability Pharmaceutical Research 12 413 420
3. Ashby J. Piddock L.J.V. Wise R. 1985 An investigation of the hydrophobicity of the quinolones Journal of Antimicrobial Chemotherapy 16 805 808
4. Asuquo A.E. Piddock L.J.V. 1993 Accumulation and killing kinetics of fifteen quinolones for Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa Journal of Antimicrobial Chemotherapy 31 865 880
5. Bermingham E. Papich M.G. Vivrette S. Bostian A. 1998 Pharmacokinetics of intravenous and oral enrofloxacin in foals Journal of Veterinary Internal Medicine 12 218
6. Bidgood T.L. Papich M.G. 2003 Comparison of plasma and interstitial fluid concentrations of doxycycline and meropenem following constant rate intravenous infusion in dogs American Journal of Veterinary Research 64 1040 1046
7. Bidgood T. Papich M.G. 2005 Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs Journal of Veterinary Pharmacology and Therapeutics 28 329 341
8. Bousquet-Melou A. Bernard S. Schneider M. Toutain P.L. 2002 Pharmacokinetics of marbofloxacin in horses Equine Veterinary Journal 34 366 372
9. Carretero M. Rodriguez C. San Andres M.I. Fores P. de Lucas J.J. Nieto J. Waxman S. San Andres M.D. Gonzalez F. 2002 Pharmacokinetics of marbofloxacin in mature horses after single intravenous and intramuscular administration Equine Veterinary Journal 34 360 365
10. Craig W.A. 1998 Pharmacokinetic/pharmacodynamic parameters: rationale for antimicrobial dosing of mice and men Clinical Infectious Diseases 26 1 12
11. Dowling P.M. Wilson R.C. Tyler J.W. Duran S.H. 1995 Pharmacokinetics of ciprofloxacin in ponies Journal of Veterinary Pharmacology and Therapeutics 18 7 12
12. Drusano G.L. Johnson D.E. Rosen M. Standiford H.C. 1993 Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis Antimicrobial Agents and Chemotherapy 37 483 490
13. Epstein K. Cohen N. Boothe D. Nieuwoudt C. Chandler J. 2004 Pharmacokinetics, stability, and retrospective analysis of use of an oral gel formulation of the bovine injectable enrofloxacin in horses Veterinary Therapeutics 5 155 167
14. Gardner S.Y. Davis J.L. Jones S.L. LaFevers D.H. Hoskins M.S. McArver E.M. Papich M.G. 2004 Moxifloxacin pharmacokinetics in horses and disposition into phagocytes after oral dosing Journal of Veterinary Pharmacology and Therapeutics 27 57 60
15. Gibaldi M. Perrier D. 1982 Pharmacokinetics 2nd edn pp 1 494 Marcel Dekker Inc. New York
16. Giguère S. Sweeney R.W. Bélanger M. 1996 Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses American Journal of Veterinary Research 57 1025 1030
17. Haines G.R. Brown M.P. Gronwall R.R. Merritt K.A. Baltzley L.K. 2001 Pharmacokinetics of orbifloxacin and its concentration in body fluids and in endometrial tissues of mares Canadian Journal of Veterinary Research 65 181 187
18. Hannan P.C. Windsor G.D. de Jong A. Schmeer N. Stegemann M. 1997 Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones Antimicrobial Agents and Chemotherapy 41 2037 2040
19. Hyatt J.M. McKinnon P.S. Zimmer G.S. Schentag J.J. 1995 The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome Clinical Pharmacokinetics 28 143 160
20. Kaartinen L. Panu S. Pyörälä S. 1997 Pharmacokinetics of enrofloxacin in horses after single intravenous and intramuscular administration Equine Veterinary Journal 29 378 381
21. KuKanich B. Papich M. 2003 Fluoroquinolone stability in vehicles for oral administration Journal of Veterinary Internal Medicine 17 449
22. Küng K. Riond J.L. Wolffram S. Wanner M. 1993 Comparison of an HPLC and bioassay method to determine antimicrobial concentrations after intravenous and oral administration of enrofloxacin in four dogs Research Veterinary Science 54 247 248
23. Lode H. Borner K. Koeppe P. 1998 Pharmacodynamics of fluoroquinolones Clinical Infectious Diseases 27 33 39
24. Martinez M. Augsburger L. Johnston T. Jones W.W. 2002 Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part I. Biopharmaceutics and formulation considerations Advanced Drug Delivery Reviews 54 805 824
25. McKellar Q.A. Sanchez Bruni S.F. Jones D.G. 2004 Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine Journal of Veterinary Pharmacology and Therapeutics 27 503 514
26. Papich M.G. Riviere J.E. 2001 Fluoroquinolone antimicrobial drugs In Veterinary Pharmacology and Therapeutics 8th edn Ed Adams H.R. pp 898 917 Iowa State University Press Ames, IA
27. Papich M.G. VanCamp S.D. Cole J. Whitacre M.D. 2002 Pharmacokinetics and endometrial tissue concentrations of enrofloxacin and the metabolite ciprofloxacin after IV administration of enrofloxacin to mares Journal of Veterinary Pharmacology and Therapeutics 25 343 350
28. Peyrou M. Doucet M.Y. Vrins A. Concordet D. Schneider M. Bousquet-Mélou A. 2004 Population pharmacokinetics of marbofloxacin in horses: preliminary analysis Journal of Veterinary Pharmacology and Therapeutics 27 283 288
29. Purcell W.P. Bass G.E. Clayton J.M. 1973 App. I. Experimental determination of partition coefficients Strategy of Drug Design. A Molecular Guide to Biological Activity pp 545 549 Wiley New York
30. Rebuelto M. Otero P. Albarellos G. Ambros L. Kreil V. Waxman S. Montoya L. Hallu R. 2000 Pharmacokinetics of fleroxacin in horses Journal of Veterinary Pharmacology and Therapeutics 23 103 105
31. Shah V.P. Midha K.K. Dighe S. 1992 Conference report: analytical methods validation: bioavailability, bioequivalence, and pharmacokinetic studies International Journal of Pharmaceutics 82 1 7
32. Vivrette S.L. Bostian A. Bermingham E. Papich M.G. 2001 Quinolone-induced arthropathy in neonatal foals Proceedings of the 47th Annual Meeting of the American Association of Equine Practitioners pp 376 377 San Diego, CA
33. Wright D.H. Brown G.H. Peterson M.L. Rotschafer J.C. 2000 Application of fluoroquinolone pharmacodynamics Journal of Antimicrobial Chemotherapy 46 669 683